Ignite Creation Date:
2024-05-05 @ 12:06 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00246012
Status:
COMPLETED
Last Update Posted:
2013-08-19
First Post:
2005-10-28
Brief Title:
A Safety and Efficacy Study of Intetumumab Alone and in Combination With Dacarbazine in Participants With Stage 4 Melanoma
Sponsor:
Organization:
Centocor Inc